X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.clinicaltrialsarena.com/news/imago-myelofibrosis-treatment-trial/
https://www.globenewswire.com/news-release/2022/12/20/2577487/0/en/Imago-BioSciences-Announces-First-Participant-Dosed-in-Investigator-Sponsored-Phase-2-Study-of-Bomedemstat-in-Combination-with-Ruxolitinib-in-Myelofibrosis.html
https://www.globenewswire.com//news-release/2022/12/12/2572137/0/en/Imago-BioSciences-Presents-Positive-Data-from-Ongoing-Phase-2-Study-of-Bomedemstat-in-Essential-Thrombocythemia-at-ASH-2022.html
https://www.globenewswire.com//news-release/2022/12/12/2572039/0/en/Imago-BioSciences-Presents-Positive-Data-from-Ongoing-Phase-2-Study-of-Bomedemstat-in-Advanced-Myelofibrosis-at-ASH-2022.html
https://www.indianpharmapost.com/news/merck-begins-tender-offer-to-acquire-imago-biosciences-13432
https://www.globenewswire.com//news-release/2022/11/30/2565433/0/en/Imago-BioSciences-Announces-First-Participant-Dosed-in-Investigator-Sponsored-Phase-1-Study-of-Bomedemstat-in-Combination-with-Venetoclax-in-Relapsed-Refractory-Acute-Myeloid-Leuke.html
https://ir.imagobio.com/news-releases/news-release-details/merck-acquire-imago-biosciences-inc
https://ir.imagobio.com/news-releases/news-release-details/imago-biosciences-reports-third-quarter-2022-financial-results
https://www.globenewswire.com/news-release/2022/11/07/2550226/0/en/Imago-BioSciences-to-Participate-in-Upcoming-Investor-Conferences.html
Market Place
Share 
